These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36603391)
1. Preclinical murine models to study lung infection with Mycobacterium abscessus complex. Nicola F; Cirillo DM; Lorè NI Tuberculosis (Edinb); 2023 Jan; 138():102301. PubMed ID: 36603391 [TBL] [Abstract][Full Text] [Related]
2. Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations. Dartois V; Bonfield TL; Boyce JP; Daley CL; Dick T; Gonzalez-Juarrero M; Gupta S; Kramnik I; Lamichhane G; Laughon BE; Lorè NI; Malcolm KC; Olivier KN; Tuggle KL; Jackson M Tuberculosis (Edinb); 2024 Jul; 147():102503. PubMed ID: 38729070 [TBL] [Abstract][Full Text] [Related]
3. Activity of Oritavancin and Its Synergy with Other Antibiotics against Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513 [TBL] [Abstract][Full Text] [Related]
4. Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice. Sriram D; Wahi R; Maggioncalda EC; Panthi CM; Lamichhane G Tuberculosis (Edinb); 2022 Dec; 137():102268. PubMed ID: 36228452 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. Cotroneo N; Stokes SS; Pucci MJ; Rubio A; Hamed KA; Critchley IA J Antimicrob Chemother; 2024 Apr; 79(4):875-882. PubMed ID: 38394463 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Efficacy of β-Lactam Combinations against Story-Roller E; Maggioncalda EC; Lamichhane G Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979 [No Abstract] [Full Text] [Related]
7. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents. Molina-Torres CA; Flores-Castillo ON; Carranza-Torres IE; Guzmán-Delgado NE; Viveros-Valdez E; Vera-Cabrera L; Ocampo-Candiani J; Verde-Star J; Castro-Garza J; Carranza-Rosales P Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):52. PubMed ID: 33222688 [TBL] [Abstract][Full Text] [Related]
9. Rifabutin Is Active against Mycobacterium abscessus in Mice. Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722 [TBL] [Abstract][Full Text] [Related]
10. Natural Products Lysobactin and Sorangicin A Show Sullivan JR; Yao J; Courtine C; Lupien A; Herrmann J; Müller R; Behr MA Microbiol Spectr; 2022 Dec; 10(6):e0267222. PubMed ID: 36342177 [TBL] [Abstract][Full Text] [Related]
11. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Johansen MD; Herrmann JL; Kremer L Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865 [TBL] [Abstract][Full Text] [Related]
14. Epetraborole Is Active against Mycobacterium abscessus. Ganapathy US; Gengenbacher M; Dick T Antimicrob Agents Chemother; 2021 Sep; 65(10):e0115621. PubMed ID: 34280020 [TBL] [Abstract][Full Text] [Related]
15. Thiostrepton: A Novel Therapeutic Drug Candidate for Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481 [No Abstract] [Full Text] [Related]
16. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151 [TBL] [Abstract][Full Text] [Related]
17. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex. Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265 [No Abstract] [Full Text] [Related]
18. Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671 [TBL] [Abstract][Full Text] [Related]
19. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice. Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632 [TBL] [Abstract][Full Text] [Related]
20. Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection. Negatu DA; González Del Río R; Cacho-Izquierdo M; Barros-Aguirre D; Lelievre J; Rullas J; Casado P; Ganapathy US; Zimmerman MD; Gengenbacher M; Dartois V; Dick T Antimicrob Agents Chemother; 2023 Feb; 67(2):e0145922. PubMed ID: 36688684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]